ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157

Dominik Feuerbach(Novartis (Switzerland)), Patrick Schindler(Novartis (Switzerland)), Carmen Barske(Novartis (Switzerland)), Stefanie Joller(Novartis (Switzerland)), Edwige Beng-Louka(Novartis (Switzerland)), Katie A. Worringer(Novartis (United States)), Sravya Kommineni(Novartis (United States)), Ajamete Kaykas(Novartis (United States)), Daniel Ho(Novartis (United States)), Chaoyang Ye(Novartis (United States)), Karl Welzenbach(Novartis (Switzerland)), Gaëlle Elain(Novartis (Switzerland)), Laurent Klein(Novartis (Switzerland)), Irena Brzak(Novartis (Switzerland)), Anis K. Mir(Novartis (Switzerland)), Christopher J. Farady(Novartis (Switzerland)), Reiner Aichholz(Novartis (Switzerland)), Simone L. Popp(Novartis (Switzerland)), Nathalie George(Novartis (Switzerland)), Ulf Neumann(Novartis (Switzerland))
Neuroscience Letters
September 18, 2017
Cited by 183

Abstract


Related Papers

No related papers found

Powered by citation graph analysis